Evidence map›Paper›PMID 34938852›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2021

A national open-access research registry to improve recruitment to clinical studies.

Piers Kotting, Adam Smith, Megan B O'Hare, Clarissa Giebel, Lakshini Mendis, Clare Shaw, Imogen Shillito, Martin N Rossor

Abstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Piers KottingDepartment of Neurodegenerative Diseases Dementia Research Centre UCL Queen Square Institute of Neurology London UK.ORCID https://orcid.org/0000-0002-7302-4914
Adam SmithDepartment of Neurodegenerative Diseases Dementia Research Centre UCL Queen Square Institute of Neurology London UK.ORCID https://orcid.org/0000-0003-3150-1206
Megan B O'HareDepartment of Neurodegenerative Diseases Dementia Research Centre UCL Queen Square Institute of Neurology London UK.
Clarissa GiebelNIHR Applied Research Collaboration North West Coast University of Liverpool Liverpool UK.ORCID https://orcid.org/0000-0002-0746-0566
Lakshini MendisDepartment of Neurodegenerative Diseases Dementia Research Centre UCL Queen Square Institute of Neurology London UK.ORCID https://orcid.org/0000-0003-1984-5954
Clare ShawNIHR Clinical Research Network Coordinating Centre University of Leeds Leeds UK.
Imogen ShillitoNIHR Clinical Research Network Coordinating Centre University of Leeds Leeds UK.
Martin N RossorDepartment of Neurodegenerative Diseases Dementia Research Centre UCL Queen Square Institute of Neurology London UK.ORCID https://orcid.org/0000-0001-8215-3120

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBarriers to recruitment for dementia studies are well documented. As part of the UK government's Dementia 2020 strategy, a nationally consistent system to increase public engagement and participation in research was launched in February 2015.

methodsWe describe the development of the "Join Dementia Research" registry, including evolution of policy, involvement of people with dementia in co-production, data requirements, governance, technology, and the impact on study recruitment and what factors may have contributed to the services success.

resultsThe UK-wide online, telephone, and postal service has registered 47,071 volunteers, with 33,139 people (67.9% of all volunteers) taking part in 378 studies, with 49,954 total study enrolments. This has taken place across 295 research sites, involved 1522 researchers, and resulted in 134 peer-reviewed publications. DISCUSSION: Public registries of individuals interested in research, with user-provided data enabling basic phenotyping, are effective at increasing public engagement with research and removing barriers to study recruitment. Deeper pheno/genotyping could be undertaken to improve matching, but how and when that information is collected will be a key factor.

Indexed as

Alzheimer's diseaseclinical trial recruitmentconsent‐for‐approachconsent‐for‐contactdementiaonline registrypublic engagementregistriesregistryresearch participationresearch recruitment

Identifiers

PMID34938852
PMCPMC8659591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.